{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T21:14:56Z","timestamp":1783718096878,"version":"3.55.0"},"reference-count":16,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aust Dent J"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1111\/adj.12254","type":"journal-article","created":{"date-parts":[[2014,12,6]],"date-time":"2014-12-06T06:54:38Z","timestamp":1417848878000},"page":"528-531","source":"Crossref","is-referenced-by-count":45,"title":["Osteonecrosis of the jaw in a patient receiving cabozantinib"],"prefix":"10.1111","volume":"60","author":[{"given":"R","family":"Marino","sequence":"first","affiliation":[{"name":"Oral Medicine and Oral Oncology Unit; Department of Oncology; University of Turin; Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"Orlandi","sequence":"additional","affiliation":[{"name":"Endocrine Unit; Department of Oncology; University of Turin; Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"Arecco","sequence":"additional","affiliation":[{"name":"Endocrine Unit; Department of Oncology; University of Turin; Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Gandolfo","sequence":"additional","affiliation":[{"name":"Oral Medicine and Oral Oncology Unit; Department of Oncology; University of Turin; Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Pentenero","sequence":"additional","affiliation":[{"name":"Oral Medicine and Oral Oncology Unit; Department of Oncology; University of Turin; Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2015,11,27]]},"reference":[{"key":"10.1111\/adj.12254-BIB0001|adj12254-cit-0001","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1016\/j.joms.2014.04.031","article-title":"American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw-2014 update","volume":"72","author":"Ruggiero","year":"2014","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1111\/adj.12254-BIB0002|adj12254-cit-0002","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/S0278-2391(03)00720-1","article-title":"Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic","volume":"61","author":"Marx","year":"2003","journal-title":"J\u00a0Oral Maxillofac Surg"},{"key":"10.1111\/adj.12254-BIB0003|adj12254-cit-0003","first-page":"268","article-title":"Bisphosphonates and avascular necrosis of the jaws","volume":"48","author":"Carter","year":"2003","journal-title":"Aust Dent J"},{"key":"10.1111\/adj.12254-BIB0004|adj12254-cit-0004","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1007\/s00520-013-2017-y","article-title":"Use of bisphosphonates and the risk of osteonecrosis among cancer patients: a systemic review and meta-analysis of the observational studies","volume":"22","author":"Lee","year":"2014","journal-title":"Supportive Care Cancer"},{"key":"10.1111\/adj.12254-BIB0005|adj12254-cit-0005","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1182\/asheducation-2006.1.356","article-title":"Bisphosphonate complications including osteonecrosis of the jaw","author":"Mehrotra","year":"2006","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1111\/adj.12254-BIB0006|adj12254-cit-0006","doi-asserted-by":"crossref","first-page":"3639","DOI":"10.1200\/JCO.2012.48.4659","article-title":"Cabozantinib in progressive medullary thyroid cancer","volume":"31","author":"Elisei","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1111\/adj.12254-BIB0007|adj12254-cit-0007","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1097\/CCO.0000000000000029","article-title":"An update on clinical trials of targeted therapies in thyroid cancer","volume":"26","author":"Haraldsdottir","year":"2014","journal-title":"Current Opin Oncol"},{"key":"10.1111\/adj.12254-BIB0008|adj12254-cit-0008","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1016\/j.surg.2012.08.031","article-title":"Novel withanolides target medullary thyroid cancer through inhibition of both RET phosphorylation and the mammalian target of rapamycin pathway","volume":"152","author":"Samadi","year":"2012","journal-title":"Surgery"},{"key":"10.1111\/adj.12254-BIB0009|adj12254-cit-0009","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1089\/thy.2013.0137","article-title":"In vitro and in\u00a0vivo activity of cabozantinib (XL184), an inhibitor of RET, MET, and VEGFR2, in a model of medullary thyroid cancer","volume":"23","author":"Bentzien","year":"2013","journal-title":"Thyroid"},{"key":"10.1111\/adj.12254-BIB0010|adj12254-cit-0010","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.2217\/fon.13.128","article-title":"Cabozantinib (XL184) for the treatment of locally advanced or metastatic progressive medullary thyroid cancer","volume":"9","author":"Viola","year":"2013","journal-title":"Future Oncol"},{"key":"10.1111\/adj.12254-BIB0011|adj12254-cit-0011","first-page":"1","article-title":"Profile of cabozantinib and its potential in the treatment of advanced medullary thyroid cancer","volume":"6","author":"Hart","year":"2013","journal-title":"Onco Targets Ther"},{"key":"10.1111\/adj.12254-BIB0012|adj12254-cit-0012","first-page":"88","article-title":"Cabozantinib approved for advanced medullary thyroid cancer","volume":"70","author":"Traynor","year":"2013","journal-title":"Am J Health Syst Pharm"},{"key":"10.1111\/adj.12254-BIB0013|adj12254-cit-0013","first-page":"c85","article-title":"Physiology and pharmacology of nonbisphosphonate drugs implicated in osteonecrosis of the jaw","volume":"78","author":"Troeltzsch","year":"2012","journal-title":"J Can Dent Assoc"},{"key":"10.1111\/adj.12254-BIB0014|adj12254-cit-0014","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.oraloncology.2009.10.004","article-title":"Osteonecrosis of the jaws induced by drugs other than bisphosphonates - a call to update terminology in light of new data","volume":"46","author":"Yarom","year":"2010","journal-title":"Oral Oncol"},{"key":"10.1111\/adj.12254-BIB0015|adj12254-cit-0015","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.oooo.2012.01.004","article-title":"Drug-related osteonecrosis of the jaws: \u2018Exposure, or not exposure: that is the question\u2019","volume":"113","author":"Mignogna","year":"2012","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"10.1111\/adj.12254-BIB0016|adj12254-cit-0016","first-page":"1793","article-title":"Denosumab and anti-angiogenetic drug-related osteonecrosis of the jaw: an uncommon but potentially severe disease","volume":"33","author":"Sivolella","year":"2013","journal-title":"Anticancer Res"}],"container-title":["Australian Dental Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fadj.12254","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/adj.12254\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,3]],"date-time":"2021-07-03T12:02:19Z","timestamp":1625313739000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/adj.12254"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11,27]]},"references-count":16,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,12]]}},"URL":"https:\/\/doi.org\/10.1111\/adj.12254","archive":["Portico"],"relation":{},"ISSN":["0045-0421"],"issn-type":[{"value":"0045-0421","type":"print"}],"subject":[],"published":{"date-parts":[[2015,11,27]]}}}